Sven Thormahlen

Keine laufenden Positionen mehr

68 Jahre

Consumer Non-Durables

Health Technology

Consumer Services

Profil

Dr. Sven Thormahlen is Chief Technology Officer at Corbion NV.
He is on the Board of Directors at Accera, Inc. Dr. Thormahlen was previously employed as Executive Vice President-Research & Development by Danone SA, Chief Executive Officer by MucoVax GmbH, Outside Director by Yakult Honsha Co., Ltd., and Senior Vice President-Research & Development by L'Oréal SA. He received his graduate degree from the University of Hamburg and a doctorate degree from the University of Hamburg.

Ehemalige bekannte Positionen von Sven Thormahlen

Unternehmen	Position	Ende
MucoVax GmbH	Vorstandsvorsitzender	-
CORBION N.V.	Technik-/Wissenschafts-/F&E-Leiter	-
L'ORÉAL	Technik-/Wissenschafts-/F&E-Leiter	-
Cerecin, Inc. Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO.	Direktor/Vorstandsmitglied	-
YAKULT HONSHA CO.,LTD.	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Sven Thormahlen im Detail an

Ausbildung von Sven Thormahlen

University of Hamburg

Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen